Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Turke A.,,MEK inhibition leads to PI3K/AKT activation by relieving a negative feedback on ERBB receptors,2012,Cancer Research,183,10.1158/0008-5472.CAN-11-3747,United States;United States,Article,Boston;Boston,1,Journal,2-s2.0-84863596086
Infante J.,,"Safety, pharmacokinetic, and pharmacodynamic phase I dose-escalation trial of PF-00562271, an inhibitor of focal adhesion kinase, in advanced solid tumors",2012,Journal of Clinical Oncology,139,10.1200/JCO.2011.38.9346,United States,Article,Nashville,0,Journal,2-s2.0-84862990976
Kumar M.,,The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer,2012,Cell,189,10.1016/j.cell.2012.02.059,United Kingdom,Article,London,1,Journal,2-s2.0-84860319361
Chen Z.,,A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response,2012,Nature,318,10.1038/nature10937,United States;United States,Article,Boston;Boston,0,Journal,2-s2.0-84862777541
De Raedt T.,,Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors,2011,Cancer Cell,165,10.1016/j.ccr.2011.08.014,United States;United States;United States,Article,Boston;Boston;Boston,1,Journal,2-s2.0-80052557069
Xue W.,,Response and resistance to NF-κB inhibitors in mouse models of lung adenocarcinoma,2011,Cancer Discovery,86,10.1158/2159-8290.CD-11-0073,United States,Article,Cambridge,1,Journal,2-s2.0-83955165140
Gysin S.,,Therapeutic strategies for targeting Ras proteins,2011,Genes and Cancer,217,10.1177/1947601911412376,United States,Article,San Francisco,1,Journal,2-s2.0-79960051265
Junttila M.R.,,Selective activation of p53-mediated tumour suppression in high-grade tumours,2010,Nature,170,10.1038/nature09526,United States;United States,Article,San Francisco;San Francisco,0,Journal,2-s2.0-78649492693
Feldser D.M.,,Stage-specific sensitivity to p53 restoration during lung cancer progression,2010,Nature,178,10.1038/nature09535,United States,Article,Chevy Chase,0,Journal,2-s2.0-78649491016
Pullikuth A.,,Extracellular signal-regulated kinase promotes rho-dependent focal adhesion formation by suppressing p190A RhoGAP,2010,Molecular and Cellular Biology,33,10.1128/MCB.01178-09,United States,Article,New Orleans,1,Journal,2-s2.0-77953400433
Frémin C.,,From basic research to clinical development of MEK1/2 inhibitors for cancer therapy,2010,Journal of Hematology and Oncology,158,10.1186/1756-8722-3-8,Canada,Review,Montreal,1,Journal,2-s2.0-77949464718
Konstantinidou G.,,Dual phosphoinositide 3-kinase/mammalian target of rapamycin blockade is an effective radiosensitizing strategy for the treatment of non-small cell lung cancer harboring K-RAS mutations,2009,Cancer Research,121,10.1158/0008-5472.CAN-09-0823,United States;Italy,Article,Dallas;Camerino,1,Journal,2-s2.0-70350228529
Singh A.,,"A Gene Expression Signature Associated with ""K-Ras Addiction"" Reveals Regulators of EMT and Tumor Cell Survival",2009,Cancer Cell,517,10.1016/j.ccr.2009.03.022,United States,Article,Boston,1,Journal,2-s2.0-65649108558
Del Re D.,,Focal adhesion kinase as a RhoA-activable signaling scaffold mediating akt activation and cardiomyocyte protection,2008,Journal of Biological Chemistry,83,10.1074/jbc.M804036200,United States,Article,San Diego,1,Journal,2-s2.0-58149092317
Golubovskaya V.M.,,"A small molecule inhibitor, 1,2,4,5-benzenetetraamine tetrahydrochloride, targeting the Y397 site of focal adhesion kinase decreases tumor growth",2008,Journal of Medicinal Chemistry,163,10.1021/jm800483v,United States;United States,Article,Gainesville;Gainesville,0,Journal,2-s2.0-57349153946
Engelman J.A.,,Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers,2008,Nature Medicine,1038,10.1038/nm.1890,United States;United States;United States,Article,Boston;Boston;Boston,0,Journal,2-s2.0-57349194139
Ding L.,,Somatic mutations affect key pathways in lung adenocarcinoma,2008,Nature,1868,10.1038/nature07423,United States,Article,St. Louis,1,Journal,2-s2.0-54549094903
Heasman S.J.,,Mammalian Rho GTPases: New insights into their functions from in vivo studies,2008,Nature Reviews Molecular Cell Biology,1236,10.1038/nrm2476,United Kingdom,Review,London,0,Journal,2-s2.0-50149083752
Xue W.,,DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma,2008,Genes and Development,138,10.1101/gad.1672608,United States,Article,Cold Spring Harbor,1,Journal,2-s2.0-44849097747
Sharma S.V.,,Oncogene addiction: Setting the stage for molecularly targeted cancer therapy,2007,Genes and Development,311,10.1101/gad.1609907,United States,Review,Boston,1,Journal,2-s2.0-37249003928
Kissil J.L.,,Requirement for Rac1 in a K-ras-induced lung cancer in the mouse,2007,Cancer Research,132,10.1158/0008-5472.CAN-07-2300,United States,Article,Philadelphia,1,Journal,2-s2.0-34548583283
Manning B.,,AKT/PKB Signaling: Navigating Downstream,2007,Cell,3954,10.1016/j.cell.2007.06.009,United States,Review,Boston,1,Journal,2-s2.0-34250788809
Wildenberg G.,,p120-Catenin and p190RhoGAP Regulate Cell-Cell Adhesion by Coordinating Antagonism between Rac and Rho,2006,Cell,299,10.1016/j.cell.2006.09.046,United States,Article,Nashville,1,Journal,2-s2.0-33751256003
Bryant P.,,Focal adhesion kinase controls cellular levels of p27/Kip1 and p21/Cip1 through Skp2-dependent and -independent mechanisms,2006,Molecular and Cellular Biology,60,10.1128/MCB.01612-05,United States,Article,Albany,1,Journal,2-s2.0-33646896769
Hezel A.F.,,Genetics and biology of pancreatic ductal adenocarcinoma,2006,Genes and Development,752,10.1101/gad.1415606,United States,Review,Boston,1,Journal,2-s2.0-33646577163
Sato M.,,"Multiple oncogenic changes (K-RAS<sup>V12</sup>, p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells",2006,Cancer Research,199,10.1158/0008-5472.CAN-05-2521,United States,Article,Dallas,1,Journal,2-s2.0-33644507072
McLean G.,,The role of focal-adhesion kinase in cancer - A new therapeutic opportunity,2005,Nature Reviews Cancer,765,10.1038/nrc1647,United Kingdom,Review,Glasgow,0,Journal,2-s2.0-21744435478
Mitra S.,,Focal adhesion kinase: In command and control of cell motility,2005,Nature Reviews Molecular Cell Biology,1713,10.1038/nrm1549,United States,Review,San Diego,0,Journal,2-s2.0-11244258882
McLean G.,,Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression,2004,Genes and Development,174,10.1101/gad.316304,United Kingdom,Article,Glasgow,1,Journal,2-s2.0-10644280092
Ramirez R.D.,,Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins,2004,Cancer Research,426,10.1158/0008-5472.CAN-04-3703,United States;United States;United States,Article,Dallas;Dallas;Dallas,1,Journal,2-s2.0-10844284696
Mammoto A.,,"Role of RhoA, mDia, and ROCK in cell shape-dependent control of the Skp2-p27<sup>kip-1</sup> pathway and the G<inf>1</inf>/S transition",2004,Journal of Biological Chemistry,177,10.1074/jbc.M402725200,United States,Article,Boston,1,Journal,2-s2.0-2942707853
Kamai T.,,Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer,2003,Clinical Cancer Research,307,,Japan;Japan,Article,Tokyo;Shimotsuga District,0,Journal,2-s2.0-0037817325
Malumbres M.,,RAS oncogenes: The first 30 years,2003,Nature Reviews Cancer,1257,10.1038/nrc1097,Spain,Review,Madrid,0,Journal,2-s2.0-0037805547
Riento K.,,Rocks: Multifunctional kinases in cell behaviour,2003,Nature Reviews Molecular Cell Biology,1402,10.1038/nrm1128,United Kingdom,Review,London,0,Journal,2-s2.0-0038024241
Brahmbhatt A.,,ERK and RhoA differentially regulate pseudopodia growth and retraction during chemotaxis,2003,Journal of Biological Chemistry,71,10.1074/jbc.M211873200,,Article,,1,Journal,2-s2.0-0038305915
Chen B.,,Roles of Rho-associated kinase and myosin light chain kinase in morphological and migratory defects of focal adhesion kinase-null cells,2002,Journal of Biological Chemistry,118,10.1074/jbc.M204429200,Taiwan;United States;United States,Article,Taichung;New York;Bronx,1,Journal,2-s2.0-0037072731
Fisher G.,,Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes,2001,Genes and Development,465,10.1101/gad.947701,United States;United States,Article,Charleston;Bethesda,1,Journal,2-s2.0-0035893318
Sherr C.,,The INK4a/ARF network in tumour suppression,2001,Nature Reviews Molecular Cell Biology,771,10.1038/35096061,United States,Review,"Memphis TN,",0,Journal,2-s2.0-0035487104
Sander E.,,Rac downregulates Rho activity: Reciprocal balance between both GTPases determines cellular morphology and migratory behavior,1999,Journal of Cell Biology,695,10.1083/jcb.147.5.1009,Netherlands,Article,Amsterdam,1,Journal,2-s2.0-0033615966
Hu W.,,RhoA stimulates p27(Kip) degradation through its regulation of cyclin E/CDK2 activity,1999,Journal of Biological Chemistry,104,10.1074/jbc.274.6.3396,United States,Article,St. Louis,1,Journal,2-s2.0-0033525188
Serrano M.,,Role of the INK4a locus in tumor suppression and cell mortality,1996,Cell,1328,10.1016/S0092-8674(00)81079-X,United States,Article,Chevy Chase,1,Journal,2-s2.0-0029993450
Phelps R.M.,,NCI-Navy Medical Oncology Branch cell line data base,1996,Journal of Cellular Biochemistry,233,10.1002/jcb.240630505,United States,Article,Bethesda,0,Journal,2-s2.0-33646953271
Qiu R.G.,,An essential role for rac in ras transformation,1995,Nature,794,10.1038/374457a0,United States,Article,Emeryville,0,Journal,2-s2.0-0028903247
Khosravi-Far R.,,"Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation",1995,Molecular and Cellular Biology,614,10.1128/MCB.15.11.6443,United States,Article,Chapel Hill,1,Journal,2-s2.0-0028800305
Warshaw A.,,Pancreatic carcinoma,1992,New England Journal of Medicine,1485,10.1056/NEJM199202133260706,United States,Review,Boston,0,Journal,2-s2.0-0027118569
